title: [Thrombolytic therapy with recombinant tissue-type plasminogen activator in patients with branch or central vein occlusion of the retina].
authors.forename: A
authors.initials: A
authors.lastname: Kreutzer
authors.forename: R
authors.initials: R
authors.lastname: Brunner
authors.forename: H J
authors.initials: HJ
authors.lastname: Schäfer
authors.forename: W
authors.initials: W
authors.lastname: Sickel
authors.forename: H
authors.initials: H
authors.lastname: Auel
authors.forename: V
authors.initials: V
authors.lastname: Hossmann
mesh_terms: D000328:Adult; D006801:Humans; D007262:Infusions, Intravenous; D008875:Middle Aged; D011994:Recombinant Proteins / Q000627:therapeutic use; D012169:Retinal Vein / Q000187:drug effects; D012170:Retinal Vein Occlusion / Q000628:therapy*; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*
chemical_list: D011994:Recombinant Proteins; D010959:Tissue Plasminogen Activator
vernacular_title: Lysetherapie mit rt-PA bei Patienten mit Stamm- oder Zentralvenenocclusion der Retina.